分子診斷數據流

這個分子診斷資料流提供下列分子診斷測試主要類別的季度市場規模。

• 分子診斷
• 感染疾病(呼吸系統，肝炎，HIV，HAI，其他)
• 腫瘤學(分子，HPV，ISH)
• 遺傳基因檢驗(遺傳性，NIPT，其他)
• 移植
• NAT血庫檢驗
• 分子醫護檢查站
• COVID檢驗

樣品

各地區市場

• 北美
• 歐洲
• 亞太地區
• 其他地區

目錄

• 每季的估計市場
• 市場區隔詳細內容
• 初期COVID試驗的估計值
• 分析師的評論和季度活動的相關註記
• 外匯效果

Kalorama Information's “ Molecular Diagnostics Datastream (23-029) ” provides market sizing by quarter for significant categories of molecular diagnostic tests, including:

• Molecular Diagnostic
• Infectious Disease (Respiratory, Hepatitis, HIV, HAIs and Others)
• Oncology (Molecular, HPV and ISH)
• Genetic Testing (Inherited and NIPT, Others)
• Transplantation
• NAT Blood Banking Tests
• Molecular Point of Care Tests
• COVID Testing

SAMPLE VIEW

Market Estimates reflect IVD manufacturer estimated revenue.

Regional Markets for each major category of molecular diagnostics testing:

• North American
• European
• APAC
• Rest of World

Includes:

• Quarterly Estimated Markets
• Segment Detail
• Early COVID Testing Estimates
• Analyst Commentary and Notes on Quarterly Events
• Currency Effects

NOTE: The Kalorama “ Molecular Diagnostics Quarterly Datastream” is only available to those who have purchased Kalorama's “Worldwide In Vitro Diagnostic Tests Report, World Molecular Diagnostics Report or Molecular Point-of-Care (POC) ” report. All in any edition. This is because this is a quarterly update to markets covered in these reports.